TR201009399A2 - Rapidly soluble effervescent rosuvastatin formulations. - Google Patents

Rapidly soluble effervescent rosuvastatin formulations.

Info

Publication number
TR201009399A2
TR201009399A2 TR2010/09399A TR201009399A TR201009399A2 TR 201009399 A2 TR201009399 A2 TR 201009399A2 TR 2010/09399 A TR2010/09399 A TR 2010/09399A TR 201009399 A TR201009399 A TR 201009399A TR 201009399 A2 TR201009399 A2 TR 201009399A2
Authority
TR
Turkey
Prior art keywords
rapidly soluble
soluble effervescent
rosuvastatin
formulations
rosuvastatin formulations
Prior art date
Application number
TR2010/09399A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09399A priority Critical patent/TR201009399A2/en
Priority to PCT/TR2011/000248 priority patent/WO2012064306A2/en
Publication of TR201009399A2 publication Critical patent/TR201009399A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, etken madde olarak rosuvastatin ve/veya farmasötik kabul edilebilir bir tuzunu içeren hızlı çözünen efervesan formülasyonlara ilişkindir.The present invention relates to fast dissolving effervescent formulations containing rosuvastatin and / or a pharmaceutically acceptable salt thereof as an active ingredient.

TR2010/09399A 2010-11-11 2010-11-11 Rapidly soluble effervescent rosuvastatin formulations. TR201009399A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/09399A TR201009399A2 (en) 2010-11-11 2010-11-11 Rapidly soluble effervescent rosuvastatin formulations.
PCT/TR2011/000248 WO2012064306A2 (en) 2010-11-11 2011-11-03 Effervescent formulations of rosuvastatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09399A TR201009399A2 (en) 2010-11-11 2010-11-11 Rapidly soluble effervescent rosuvastatin formulations.

Publications (1)

Publication Number Publication Date
TR201009399A2 true TR201009399A2 (en) 2012-05-21

Family

ID=45607337

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09399A TR201009399A2 (en) 2010-11-11 2010-11-11 Rapidly soluble effervescent rosuvastatin formulations.

Country Status (2)

Country Link
TR (1) TR201009399A2 (en)
WO (1) WO2012064306A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (en) 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives
EP0872544A1 (en) * 1997-04-14 1998-10-21 The Procter & Gamble Company Dry effervescent granules and granular compositions comprising the same
US20070048375A1 (en) * 2003-12-19 2007-03-01 Wolfgang Wiehl Effervescent preparation of a basic medicinally active substance
WO2006037348A1 (en) * 2004-10-01 2006-04-13 Lifecycle Pharma A/S Pharmaceutical compositions comprising fenofibrate and a statin
WO2006134604A1 (en) * 2005-06-15 2006-12-21 Hetero Drugs Limited Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor
WO2008062476A2 (en) * 2006-10-31 2008-05-29 Glenmark Pharmaceutical Limited Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
US20090304602A1 (en) * 2008-06-06 2009-12-10 Tuchinsky David B Nutritional supplement
PL386051A1 (en) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stable, oral compound pharmaceutical containing pharmaceutically permissible content of [(E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3R,5S)-3,5-dihydroxy-hept-6-enoate acid salt
CN101618215A (en) * 2009-08-16 2010-01-06 王丽燕 Pharmaceutical composition containing calcium blocker, AII receptor blocker and statins
TR201009397A2 (en) * 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Pharmaceutical compositions containing rosuvastatin.
EP2575757A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Water soluble formulation comprising a combination of amlodipine and a statin

Also Published As

Publication number Publication date
WO2012064306A2 (en) 2012-05-18
WO2012064306A3 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
EA201201263A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DAGIGATRAN ETEXYLATE
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
UA111717C2 (en) ORAL INTRODUCTION AND METHYLNALTREXON LIPOPHILIC SALTS
MY183312A (en) Pharmaceutical formulation
EA201201325A1 (en) PESTICIDAL MIXTURES
MX341200B (en) A fast dissolving pharmaceutical composition.
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
PH12015501096A1 (en) Composition for immediate and extended release
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
UA115357C2 (en) Pyridin-4-yl derivatives
MX347105B (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
MX2016003754A (en) A stable pharmaceutical composition containing amlodipine and valsartan.
TR201009394A2 (en) Improved montelukast formulations.
EP2871187A4 (en) Novel compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient
TR200806300A2 (en) Solubility enhancing pharmaceutical formulation
UA109804C2 (en) 2-methoxypyridine-4-yl derivatives
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
TR201803451T4 (en) OLMESARTAN FORMULATIONS.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
EP2842938A4 (en) Novel beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient
WO2013072770A3 (en) Pharmaceutical formulations comprising atorvastatin and glimepiride
TR201010859A2 (en) Tablet forms containing cefdinir.
TR201009395A2 (en) Effervescent formulations with improved taste.
TR201009165A2 (en) Tablets containing cefdinir